prehospItal maNagement oF paroxysmaL supraventrICular Tachycardia

NCT ID: NCT06077799

Last Updated: 2025-04-13

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

1234 participants

Study Classification

OBSERVATIONAL

Study Start Date

2023-06-14

Study Completion Date

2024-10-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Retrospective multicentre study on management of supraventricular tachycardia in prehospital setting.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Supraventricular tachycardia in prehospital setting may be managed with adenosine administration or with synchronised electrical cardioversion and there's no clear advantage between the two, even if international guidelines suggests to practice drug-first method.This study aims to evaluate any difference in outcomes and efficacy of the two methods and possible adverse effects of both.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Tachycardia, Supraventricular

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

RETROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

supraventricular tachycardia treated with intra-venous adenosine

supraventricular tachycardia treated with intra-venous adenosine

No interventions assigned to this group

supraventricular tachycardia treated with electrical synchronised cardioversion

supraventricular tachycardia treated with electrical synchronised cardioversion

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* patients accepting to participate
* patients affected by supraventricular tachycardia that are managed prehospitally by the emergency medical service

Exclusion Criteria

* not willing to participate, not able to give consent
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Azienda Regionale Emergenza Urgenza - AREU Lombardia

OTHER

Sponsor Role collaborator

Azienda Ospedaliero Universitaria Maggiore della Carita

OTHER

Sponsor Role collaborator

Azienda Usl di Bologna

OTHER_GOV

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Azienda Unità Sanitaria Locale

Bologna, Bologna, Italy

Site Status

Agenzia Regionale Emergenza Urgenza (AREU), Dipartimento di Emergenza e Accettazione, ASST Grande Ospedale Metropolitano Niguarda

Milan, Italy, Italy

Site Status

Azienda Ospedaliera Universitaria Maggiore della Carità, Novara, Italy

Novara, Italy, Italy

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Italy

References

Explore related publications, articles, or registry entries linked to this study.

Gamberini L, Carinci V, Pallavicini P, Rovera M, Tartaglione M, Gioachin R, D'ambrosio A, Fiameni R, Baroncini S, Allegri D, Coniglio C, Semeraro F, Ristagno G; INFLICT working group. Prehospital management of supraventricular tachycardia: a multicentre study of current practices with a subgroup propensity score-based comparison of adenosine and electrical cardioversion in unstable patients. Resuscitation. 2025 Oct;215:110707. doi: 10.1016/j.resuscitation.2025.110707. Epub 2025 Jul 7.

Reference Type DERIVED
PMID: 40633750 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

296-2023-OSS-AUSLBO

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.